Hansoh Pharmaceutical Group Company Limited Share Price
Stocks
3692
KYG549581067
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.78 HKD | +0.27% |
|
+3.47% | -17.46% |
| 06-11 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 06-10 | Hansoh Pharmaceutical's Application for HS-10568 Injection Accepted in China | MT |
| Market Cap | 156B 181B 23.05B 19.86B 18.29B 17.17B 32.24B 2,179B 32.58B 216B 84.2B 1,067B 86.5B 84.66B 3,698B | P/E Ratio 2026 * |
26.1x | P/E Ratio 2027 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 121B 140B 17.91B 15.44B 14.21B 13.35B 25.06B 1,694B 25.32B 168B 65.44B 829B 67.22B 65.79B 2,874B | EV / Sales 2026 * |
7.14x | EV / Sales 2027 * | 6.23x |
| Free-Float |
20.45% | Yield 2026 * |
1.38% | Yield 2027 * | 1.49% |
| 1 day | +0.27% | ||
| 1 week | +3.47% | ||
| Current month | -5.28% | ||
| 1 month | -15.30% | ||
| 3 months | -8.65% | ||
| 6 months | -25.06% | ||
| Current year | -17.46% |
| 1 week | 28.24 |  | 30.28 |
| 1 month | 28.06 | | 35.16 |
| Current year | 28.06 | | 44.22 |
| 1 year | 26.8 | | 44.22 |
| 3 years | 9.41 | | 44.22 |
| 5 years | 9.41 | | 44.22 |
| 10 years | 9.41 | | 46.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 65 | 01/12/2015 |
Min Hu
DFI | Director of Finance/CFO | 49 | 31/08/2019 |
Shan Jiang
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hui Juan Zhong
CHM | Chairman | 65 | 01/12/2015 |
Ai Feng Lyu
BRD | Director/Board Member | 49 | 10/03/2016 |
Yu An Sun
BRD | Director/Board Member | 39 | 01/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Other | 109,010 | 0.0018% | |||
| 04-19 | Other | 300,000 | 0.0050% | |||
| 26/06/25 | Other | Director | 298,717 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.27% | +3.47% | +1.29% | +126.29% | 22.98B | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,007B | |
| -0.20% | -0.77% | +51.51% | +43.20% | 567B | |
| +0.40% | -1.31% | +16.56% | +60.47% | 392B | |
| -1.18% | +1.05% | +20.91% | +18.37% | 328B | |
| -0.43% | +2.01% | +23.20% | +32.46% | 277B | |
| +0.64% | -3.71% | +20.92% | +13.67% | 275B | |
| -1.86% | +3.05% | -45.70% | -49.24% | 196B | |
| -0.77% | +0.95% | +17.69% | +51.46% | 189B | |
| +2.36% | +1.38% | +14.80% | +61.34% | 154B | |
| Average | -0.14% | +0.69% | +16.02% | +50.87% | 340.9B | |
| Weighted average by Cap. | -0.31% | -0.36% | +26.61% | +67.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.95B 19.64B 2.51B 2.16B 1.99B 1.87B 3.51B 237B 3.54B 23.51B 9.16B 116B 9.41B 9.21B 402B | 18.59B 21.55B 2.75B 2.37B 2.18B 2.05B 3.85B 260B 3.89B 25.79B 10.05B 127B 10.32B 10.1B 441B |
| Net income | 5.9B 6.84B 873M 752M 693M 650M 1.22B 82.52B 1.23B 8.18B 3.19B 40.41B 3.28B 3.21B 140B | 6.52B 7.55B 964M 831M 765M 718M 1.35B 91.15B 1.36B 9.04B 3.52B 44.64B 3.62B 3.54B 155B |
| Net Debt | -34.72B -40.23B -5.14B -4.43B -4.08B -3.83B -7.18B -486B -7.26B -48.16B -18.76B -238B -19.27B -18.86B -824B | -40.03B -46.39B -5.92B -5.1B -4.7B -4.41B -8.28B -560B -8.37B -55.52B -21.63B -274B -22.22B -21.75B -950B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 29.78 $ | +0.27% | 6,901,899 |
| 15/06/26 | 29.70 $ | -0.93% | 8,226,184 |
| 12/06/26 | 29.98 $ | +2.60% | 15,406,640 |
| 11/06/26 | 29.22 $ | -0.27% | 11,227,850 |
| 10/06/26 | 29.30 $ | +2.59% | 7,832,773 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3692 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition